More than half of Asian Americans and nearly half of Hispanic Americans with diabetes are undiagnosed, according to researchers from the National Institutes of Health and the Centers for Disease Control and Prevention. Their results were published Sept. 8 in JAMA, the .
Additionally, prevalence of diabetes for all American adults went up, from nearly 10 percent to over 12 percent between 1988 and 2012. Diabetes prevalence – how common the condition is – also went up in every age, sex, level of education, income and racial/ethnic subgroup. One bright spot: The proportion of people with diabetes that was undiagnosed decreased 23 percent between 1988-1994 and 2011-2012. The statistics account for age differences across the surveys.
Using newly available 2011-2012 data from the CDC’s National Health and Nutrition Examination Survey (NHANES), researchers were able to quantify diabetes prevalence for Asian Americans for the first time and found that they have the highest proportion of diabetes that was undiagnosed among all ethnic and racial subgroups studied, at 51 percent. Diabetes was also common in Asian Americans, at 21 percent. Hispanic Americans had the highest prevalence of diabetes at nearly 23 percent, with 49 percent of that undiagnosed.
One difference between Asian Americans and the other groups studied, however, is that Asian Americans often develop type 2 diabetes at a lower body mass index (BMI). The NHANES data showed the average BMI for all Asian Americans surveyed was under 25. For the U.S. population overall, the average BMI was just below 29. A BMI of 25 to under 30 is considered overweight, and a BMI of 30 or greater is considered obese. The American Diabetes Association recommends Asian Americans get tested for diabetes at a BMI of 23 or higher, a lower BMI threshold than the general population.
“The large proportion of people with undiagnosed diabetes points to both a greater need to test for type 2 diabetes and a need for more education on when to test for type 2 diabetes, especially since populations such as Asian Americans may develop type 2 at a lower body mass than other groups,” said the study’s senior author, Catherine Cowie, Ph.D., director of diabetes epidemiology programs at the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
Researchers used NHANES results from 26,415 adults between 1988 and 2012. For the 2011-2012 survey, NHANES surveyed a disproportionate number of Asian Americans.
“By NHANES surveying a much larger group of Asian Americans to provide more precise statistics, we’re able to identify with hard data a problem that had not been well-studied in the past,” said first author Andy Menke, Ph.D., an NIDDK contractor. “However, the Asian population is diverse, and we do not yet have data on differences within that population. Getting more specific data on Asian and other subgroups may help better pinpoint education and diagnosis efforts.”
About 1 in 5 non-Hispanic black adults had diabetes, higher than the overall population. However, they had a lower proportion of diabetes that was undiagnosed than the Asian or Hispanic subgroups, with about 37 percent being undiagnosed. Non-Hispanic whites had the lowest prevalence of diabetes at 11 percent, and they had the lowest proportion of undiagnosed, at just over 32 percent.
In type 1 diabetes, the body does not make insulin. In type 2 diabetes — the most common type, which has increased along with the obesity epidemic — the body does not make or use insulin well. Both types of diabetes have potential complications including heart, kidney, nerve and eye diseases.
“By learning more about who has diabetes – and who has the disease but does not know it – we can better target research and prevention efforts,” said NIDDK Director Griffin P. Rodgers, M.D. “We have treatments to help people with diabetes, but treatments can only help those who have been diagnosed. I hope our research can serve as a reminder for people at risk for diabetes to get screened for this potentially devastating disease.”
NIDDK provides free diabetes-related information and education resources at http://www.diabetes.niddk.nih.gov and through the National Diabetes Education Program, a partnership between NIH and the CDC, at http://www.ndep.nih.gov.
This study was conducted by the NIDDK, with contractors from Social and Scientific Systems, Inc., supported under NIDDK contract GS10F0381L and by the CDC. This study supports the Healthy People 2020 goal of increasing the diagnosis of diabetes among those with the disease.
The NIDDK, a component of the NIH, conducts and supports research on diabetes and other endocrine and metabolic diseases; digestive diseases, nutrition and obesity; and kidney, urologic and hematologic diseases. Spanning the full spectrum of medicine and afflicting people of all ages and ethnic groups, these diseases encompass some of the most common, severe and disabling conditions affecting Americans. For more information about the NIDDK and its programs, see http://www.niddk.nih.gov.
About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
NIH…Turning Discovery Into Health®